29.08.2016 M1 Kliniken AG  DE000A0STSQ8

DGAP-News: M1 Kliniken AG - H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services


 
DGAP-News: M1 Kliniken AG / Key word(s): Half Year Results/Dividend M1 Kliniken AG - H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services 29.08.2016 / 10:12 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Corporate News of M1 Kliniken AG: H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services In the first half-year 2016 M1 Kliniken AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 18.5 million (previous year total: EUR 34.9 million) and an operating result (EBIT) of EUR 3.0 million (previous year total: EUR 7.0 million). "The clinic in Berlin received on April 14th 2016 the concession for the enlargement to six operating rooms and 34 patient beds. In Germany we are now active with twelve M1-outpatient service centres. The expansion of capacities will allow M1 further growth in the course of the year 2016", says Patrick Brenske, Member of the Management Board of M1 Kliniken AG. About M1 Klinken AG: M1 Kliniken AG is one of the leading private providers of health care services in the medical beauty market. M1 group offers products and services "Made in Germany" to customers throughout Germany with a broad spectrum of aesthetic and surgical treatments. Experienced and highly specialised teams of medical specialists use high- class products and state-of-the-art medical technology for minimally invasive surgery and plastic surgery on highest quality standards. M1 Kliniken AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange. Key figures for the share of M1 Kliniken AG: Subscribed capital: EUR 15,000,000 Listed shares: bearer shares ISIN: DE000A0STSQ8 WKN: A0STSQ Stock symbol: M12 Contact: M1 Kliniken AG Grünauer Straße 5 D-12557 Berlin Phone: +49 (0)30 887 086 225 Fax: +49 (0)30 887 086 228 E-Mail: [email protected] Web: www.m1-kliniken.ag --------------------------------------------------------------------------- 29.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- 496491 29.08.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 47,19 65,21 77,27 159,59 314,61 285,29 302,00
EBITDA1,2 6,18 7,17 11,33 8,89 17,82 15,41 19,85
EBITDA-Marge3 13,10 11,00 14,66 5,57 5,66 5,40
EBIT1,4 5,71 6,46 7,93 4,41 12,13 9,35 14,40
EBIT-Marge5 12,10 9,91 10,26 2,76 3,86 3,28 4,77
Jahresüberschuss1 5,78 6,61 9,73 7,43 10,88 7,07 9,50
Netto-Marge6 12,25 10,14 12,59 4,66 3,46 2,48 3,15
Cashflow1,7 2,09 2,86 -5,37 9,54 15,68 20,77 0,00
Ergebnis je Aktie8 0,38 0,39 0,56 0,37 0,45 0,22 0,39
Dividende8 0,30 0,30 0,00 0,00 0,00 0,00 0,30
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: wetreu NTRG

INVESTOR-INFORMATIONEN
©boersengefluester.de
M1 Kliniken
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0STSQ 12,700 Kaufen 249,47
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
18,41 27,97 0,65 33,51
KBV KCV KUV EV/EBITDA
2,55 12,01 0,87 15,46
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 17.07.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
06.06.2024 03.09.2024 16.11.2023 23.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
5,82% 31,32% 13,39% 102,23%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu M1 Kliniken AG  ISIN: DE000A0STSQ8 können Sie bei EQS abrufen


Gesundheit , A0STSQ , M12 , XETR:M12